scholarly journals Fibrillar collagen injection for organ protection during thermal ablation of hepatic malignancies

2017 ◽  
Vol 23 (5) ◽  
pp. 381-384 ◽  
Author(s):  
Bill S. Majdalany ◽  
Jonathan Willatt ◽  
Jeffrey Forris Beecham Chick ◽  
Ravi N. Srinivasa ◽  
Wael A. Saad
Keyword(s):  
Thermal Ablation ◽  
Fibrillar Collagen ◽  
Organ Protection ◽  
Collagen Injection ◽  
Hepatic Malignancies

Thermal Ablation for Primary and Metastatic Hepatic Malignancies

2010 ◽  
Vol 29 (4) ◽  
pp. 102-108
Author(s):  
Kathy W. Taylor ◽  
Gail Egan Sansivero
Keyword(s):  
Thermal Ablation ◽  
Hepatic Malignancies

Safety of Hydroinfusion in Percutaneous Thermal Ablation of Hepatic Malignancies

2014 ◽  
Vol 25 (7) ◽  
pp. 1118-1124 ◽  
Author(s):  
Justin P. McWilliams ◽  
Adam N. Plotnik ◽  
Eric Y. Sako ◽  
Steven S. Raman ◽  
Nelly Tan ◽  
...  
Keyword(s):  
Thermal Ablation ◽  
Percutaneous Thermal Ablation ◽  
Hepatic Malignancies

629: Novel Laser Activated Gold Nanoshell Thermal Ablation of Human Prostate Cancer in Vivo

2007 ◽  
Vol 177 (4S) ◽  
pp. 210-211 ◽  
Author(s):  
Joshua M. Stern ◽  
Jennifer Stanfield ◽  
Jer-Tsang Hsieh ◽  
Jeffrey A. Cadeddu
Keyword(s):  
Prostate Cancer ◽  
Thermal Ablation ◽  
Human Prostate ◽  
Human Prostate Cancer ◽  
Gold Nanoshell

Endovenous radiofrequency powered segmental thermal ablation (Closure FAST) of great saphenous veins

Phlebologie ◽  
2010 ◽  
Vol 39 (02) ◽  
pp. 69-71 ◽  
Author(s):  
T. M. Proebstle ◽  
Keyword(s):  
Side Effects ◽  
Thermal Ablation ◽  
Clinical Success ◽  
Clinical Success Rate ◽  
Duplex Ultrasound ◽  
Multicenter Trial ◽  
Saphenous Veins ◽  
Clinical Control ◽  
Prospective Multicenter Trial

Summary Background: Radiofrequency powered segmental thermal ablation Closure FAST has become a globally engaged technology for ablation of incompetent great saphenous veins (GSVs). Mid-term results of slowly resolving side effects are still not described. Methods: RSTA-treated GSVs (n = 295) were followed for 24 months in a prospective multicenter trial. Clinical control visits included flow and reflux analysis by duplex-ultrasound and assessment of treatment related side effects at all times. Results: 280 of 295 treated GSVs (94.9%) were available for 24 months follow-up. According to the method of Kaplan and Meier at 24 months after the intervention 98.6% of treated legs remained free of clinically relevant axial reflux. The average VCSS score improved from 3.9 ± 2.1 at screening to 0.7 ± 1.2 at 24 months follow-up (p < 0.0001). While only 41.1% of patients were free of pain before treatment, at 24 months 99.3% reported no pain and 96.4% did not experience pain during the 12 months before. At 24 months n=3 legs showed pigmentation along the inner thigh and one leg showed study-treatment related paresthesia. Conclusion: Radiofrequency powered segmental thermal ablation Closure FAST showed a very moderate side-effect profile in conjunction with a high and durable clinical success rate.

Sign in / Sign up

Export Citation Format

Share Document